Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
METTL5 pseudogene 1 (METTL5P1) is a non-coding genomic sequence that closely resembles the protein-coding METTL5 gene but does not produce a functional protein product. As a pseudogene, METTL5P1 does not encode a functional methyltransferase and has no established biological activity or relevance as a therapeutic target. Functional studies, clinical associations, and pharmacological targeting efforts focus on the active methyltransferase METTL5, not the pseudogene METTL5P1[1][3][4]. If information about drug targeting, molecular function, or disease involvement is required, the query should be directed toward METTL5 (methyltransferase 5, N6-adenosine), not its pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on METTL5 pseudogene 1 (METTL5P1).